0001209191-18-045819.txt : 20180808
0001209191-18-045819.hdr.sgml : 20180808
20180808161412
ACCESSION NUMBER: 0001209191-18-045819
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180806
FILED AS OF DATE: 20180808
DATE AS OF CHANGE: 20180808
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Horn Patrick Taylor
CENTRAL INDEX KEY: 0001572002
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33451
FILM NUMBER: 181001502
MAIL ADDRESS:
STREET 1: C/O TETRAPHASE PHARMACEUTICALS, INC.
STREET 2: 480 ARSENAL STREET, SUITE 110
CITY: WATERTOWN
STATE: MA
ZIP: 02472
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ALBIREO PHARMA, INC.
CENTRAL INDEX KEY: 0001322505
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10 POST OFFICE SQUARE
STREET 2: SUITE 502 SOUTH
CITY: BOSTON
STATE: MA
ZIP: 02109
BUSINESS PHONE: 857-415-4774
MAIL ADDRESS:
STREET 1: 10 POST OFFICE SQUARE
STREET 2: SUITE 502 SOUTH
CITY: BOSTON
STATE: MA
ZIP: 02109
FORMER COMPANY:
FORMER CONFORMED NAME: Biodel Inc
DATE OF NAME CHANGE: 20050331
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-08-06
0
0001322505
ALBIREO PHARMA, INC.
ALBO
0001572002
Horn Patrick Taylor
C/O ALBIREO PHARMA, INC.
10 POST OFFICE SQUARE, SUITE 502 SOUTH
BOSTON
MA
02109
0
1
0
0
Chief Medical Officer
Stock Option (right to buy)
31.54
2018-08-06
4
A
0
37500
0.00
A
2028-08-05
Common Stock
37500
37500
D
This option vests and becomes exercisable as to 25% of the underlying shares on August 6, 2019 and the remainder in equal quarterly installments through the fourth anniversary of the date of grant.
Jason Duncan, Attorney-in-fact
2018-08-08